Discover the reasons behind recurring nosebleeds beyond dry air, including medication effects, clotting disorders, structural ...

The company's approved ANDA is therapeutically equivalent to AstraZeneca Pharmaceuticals's Brilinta Tablets, 60 mg and 90 mg, it added.

For patients newly diagnosed with AF during hospitalization for other causes, most are not dispensed anticoagulants in the year after discharge.